000 | 01848 a2200517 4500 | ||
---|---|---|---|
005 | 20250516124955.0 | ||
264 | 0 | _c20130603 | |
008 | 201306s 0 0 eng d | ||
022 | _a1540-0514 | ||
024 | 7 |
_a10.1097/SHK.0b013e3182793e2e _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaia, Rafael Simone | |
245 | 0 | 0 |
_aCardiovascular and inflammatory response to cholecystokinin during endotoxemic shock. _h[electronic resource] |
260 |
_bShock (Augusta, Ga.) _cJan 2013 |
||
300 |
_a104-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta _xenzymology |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCholecystokinin _xantagonists & inhibitors |
650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
650 | 0 | 4 |
_aEndotoxemia _xblood |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 |
_aHypotension _xprevention & control |
650 | 0 | 4 |
_aInflammation Mediators _xblood |
650 | 0 | 4 |
_aInterleukin-10 _xblood |
650 | 0 | 4 |
_aLactic Acid _xblood |
650 | 0 | 4 | _aLipopolysaccharides |
650 | 0 | 4 |
_aLiver _xenzymology |
650 | 0 | 4 |
_aMacrophages, Peritoneal _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xbiosynthesis |
650 | 0 | 4 |
_aProglumide _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aShock, Septic _xblood |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
650 | 0 | 4 |
_aVasopressins _xblood |
700 | 1 | _aBertozi, Giuliana | |
700 | 1 | _aMestriner, Fabíola Leslie | |
700 | 1 | _aAntunes-Rodrigues, José | |
700 | 1 | _aQueiróz Cunha, Fernando | |
700 | 1 | _aCárnio, Evelin Capellari | |
773 | 0 |
_tShock (Augusta, Ga.) _gvol. 39 _gno. 1 _gp. 104-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/SHK.0b013e3182793e2e _zAvailable from publisher's website |
999 |
_c22352817 _d22352817 |